SCHEMBL18376243

SCHEMBL18376243

CN1CCN(c2cccc(Nc3ncc4cccc(-c5ccc(NC(=O)C6CC6)cc5)c4n3)c2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 6/20 0.60
▸ JAK2 O60674 8/20 0.55
▸ FGFR1 P11362 2/20 0.54
▸ KDR P35968 2/20 0.54
▸ EGFR P00533 2/20 0.53
▸ ABL1 P00519 1/20 0.52
▸ FGFR2 P21802 2/20 0.51
▸ CDK2 P24941 3/20 0.49
▸ CCNT1 O60563 1/20 0.49
▸ CCNE1 P24864 1/20 0.49
▸ CDK9 P50750 1/20 0.49
▸ JAK1 P23458 4/20 0.49
▸ JAK3 P52333 4/20 0.49
▸ BRD2 P25440 1/20 0.49
▸ BRD3 Q15059 1/20 0.49
▸ BRDT Q58F21 1/20 0.49
▸ ABCB1 P08183 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ PTK2 Q05397 1/20 0.47
▸ AURKA O14965 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18377048 0.92 EGFR (0.61) BRD4JAK2EGFRFGFR2CDK2
SCHEMBL18377033 0.90 JAK2 (0.58) BRD4JAK2FGFR1KDREGFR
SCHEMBL18376722 0.85 JAK2 (0.60) BRD4JAK2FGFR1KDREGFR
SCHEMBL29371867 0.85 JAK2 (0.60) BRD4JAK2FGFR1KDREGFR
SCHEMBL18376729 0.85 JAK2 (0.53) BRD4JAK2FGFR1KDREGFR
SCHEMBL18376724 0.85 JAK2 (0.53) BRD4JAK2FGFR1KDREGFR
SCHEMBL29368444 0.85 JAK2 (0.53) BRD4JAK2FGFR1KDREGFR
SCHEMBL18377035 0.84 BRD4 (0.66) BRD4JAK2JAK1JAK3BRD2
SCHEMBL29368267 0.84 BRD4 (0.66) BRD4JAK2JAK1JAK3BRD2
SCHEMBL18376225 0.84 JAK2 (0.59) BRD4JAK2FGFR1KDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 — — WO disclosed
Send feedback